BONE IS CONTINUALLY REMODELED BY THE COUPLED ACTIONS of osteoclasts an
d osteoblasts. This cellular remodeling occurs in discrete packets of
tissue and is regulated by both systemic and locally-produced factors
such as arachidonic acid metabolites, growth factors, and cytokines. O
steoclasts appear to be the effector cells in the resorptive process w
ith the capacity to both dissolve the mineral by proton pumps which lo
wer the local pH as well as to hydrolyze the organic matrix by secrete
d enzymes. Osteoblasts, however, also are involved in the regulation o
f osteoclastic cell activity and may thus prime bone surfaces by chang
es in cellular morphology as well as mediate the effects of resorptive
agents by post-receptor signal transduction mechanisms. Osteoblastic
cells may produce a number of cytokine-like molecules which can be inv
olved in the regulation of osteoclastogenesis. The osteoblast-like cel
ls also appear to have specific receptors for resorptive agents and me
diate their effects via a series of intracellular responses. One pathw
ay involves cyclic 3', 5' adenosine monophosphate (cyclic AMP) and the
second involves membrane phospholipids, diacylglycerol, protein kinas
e C, and cytosolic calcium. There is also emerging evidence that proto
-oncogenes may be involved in regulation of the proliferation and even
tual differentiation of osseous cells. The primary goal of this paper
is to present current studies and hypotheses involving the biochemical
and molecular mechanisms involved in the regulation of bone metabolis
m.